CA2392948A1 - Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants - Google Patents

Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants Download PDF

Info

Publication number
CA2392948A1
CA2392948A1 CA002392948A CA2392948A CA2392948A1 CA 2392948 A1 CA2392948 A1 CA 2392948A1 CA 002392948 A CA002392948 A CA 002392948A CA 2392948 A CA2392948 A CA 2392948A CA 2392948 A1 CA2392948 A1 CA 2392948A1
Authority
CA
Canada
Prior art keywords
sequence
misc
feature
polymorphic
nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002392948A
Other languages
English (en)
Inventor
Richard A. Shimkets
Martin Leach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2392948A1 publication Critical patent/CA2392948A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)

Abstract

Cette invention se rapporte à des acides nucléiques contenant des polymorphismes mononucléotidiques identifiés pour des séquences humaines transcrites, ainsi qu'à des procédés d'utilisation de ces acides nucléiques.
CA002392948A 1999-11-30 2000-11-30 Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants Abandoned CA2392948A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16813899P 1999-11-30 1999-11-30
US60/168,138 1999-11-30
US72617300A 2000-11-29 2000-11-29
US09/726,173 2000-11-29
PCT/US2000/032758 WO2001040521A2 (fr) 1999-11-30 2000-11-30 Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants

Publications (1)

Publication Number Publication Date
CA2392948A1 true CA2392948A1 (fr) 2001-06-07

Family

ID=26863832

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002392948A Abandoned CA2392948A1 (fr) 1999-11-30 2000-11-30 Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants

Country Status (5)

Country Link
EP (1) EP1235936A2 (fr)
JP (1) JP2004508003A (fr)
AU (1) AU1940001A (fr)
CA (1) CA2392948A1 (fr)
WO (1) WO2001040521A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338937B2 (en) * 1997-11-17 2008-03-04 Cornell Research Foundation, Inc. Calcium-activated chloride channel proteins and their use in anti-metastatic therapy
AU2001281062A1 (en) * 2000-08-03 2002-02-18 Genaissance Pharmaceuticals, Inc. Haplotypes of the or1g1 gene
US7317077B2 (en) 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
EP1540014A2 (fr) * 2002-08-27 2005-06-15 Epigenomics AG Procede et acides nucleiques servant a l'analyse de troubles lies a la proliferation des cellules mammaires
US7632640B2 (en) 2003-12-08 2009-12-15 The Clinic For Special Children Association of TSPYL polymorphisms with SIDDT syndrome
US7365058B2 (en) 2004-04-13 2008-04-29 The Rockefeller University MicroRNA and methods for inhibiting same
ATE469168T1 (de) * 2005-12-16 2010-06-15 Nat Cancer Ct Peptide zur transglutaminase-hemmung
AU2007249286B2 (en) 2006-05-12 2013-06-13 Gen-Probe Incorporated Compositions and methods to detect enterococci nucleic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858659A (en) * 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US6054632A (en) * 1996-11-15 2000-04-25 New York Blood Center, Inc. Method of making monoclonal antibodies using polymorphic transgenic animals
CA2274317A1 (fr) * 1996-12-02 1998-07-16 Biocem S.A. Sequences vegetales comprenant un site polymorphe et utilisation de celles-ci
WO1998038846A2 (fr) * 1997-03-07 1998-09-11 Affymetrix, Inc. Compositions genetiques et procedes

Also Published As

Publication number Publication date
JP2004508003A (ja) 2004-03-18
EP1235936A2 (fr) 2002-09-04
WO2001040521A2 (fr) 2001-06-07
AU1940001A (en) 2001-06-12
WO2001040521A3 (fr) 2002-05-16

Similar Documents

Publication Publication Date Title
CA2566256C (fr) Polymorphismes genetiques associes a des techniques de detection de cirrhose du foie et utilisation de ces polymorphismes
CN101874120B (zh) 作为用于乳腺癌风险评估、诊断、预后和治疗的标记的chr2和chr16的遗传性变型
WO2001047944A2 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
CN101641451A (zh) chr8q24.21上的癌症易感性变体
CN107532200B (zh) 用于对pkd1基因及pkd2基因的外显子进行扩增的引物组及方法
US6670464B1 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
US20030099958A1 (en) Diagnosis and treatment of vascular disease
CA2392948A1 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
CA2651376A1 (fr) Procede de diagnostic et de traitement d'une maladie mentale
EP1282726A2 (fr) Acides nucleiques contenant des polymorphismes de nucleotides simples, et procedes d'utilisation correspondants
WO2006022634A1 (fr) Méthodes d’identification du risque d’apparition de diabètes de type ii et traitements associés
US20040235041A1 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
CA2395607A1 (fr) Acides nucleiques renfermant des polymorphismes de nucleotide simple et procede d'utilisation associe
US20040235026A1 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU1915700A (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU2004203849B2 (en) Nucleic Acids Containing Single Nucleotide Polymorphisms and Methods of Use Thereof
US20030224413A1 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
US20030009016A1 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
JP2004000115A (ja) 糖尿病の発症危険性判定方法
WO2001090161A2 (fr) Acides nucleiques contenant des polymorphismes de nucleotides uniques et leurs procedes d'utilisation
CA2826522A1 (fr) Polymorphisme genetique dans pnpla3 associe aux procedes de detection d'une fibrose du foie et leurs utilisations
US20030219810A1 (en) Polymorphisms in the human CARD4 gene
WO2001047942A2 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation de ces acides
EP1244688A1 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
CN1936017A (zh) 胰升糖素样肽－1受体基因多态性与2型糖尿病的相关性

Legal Events

Date Code Title Description
FZDE Dead